Stock Analysis on Net
Stock Analysis on Net

Pfizer Inc. (NYSE:PFE)

Paying users zone. Data is hidden behind: .

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Pfizer Inc. pages available today for free:

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Pfizer Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Short-term borrowings, including current portion of long-term debt
Trade accounts payable
Dividends payable
Income taxes payable
Accrued compensation and related items
Other current liabilities
Liabilities held for sale
Current liabilities
Long-term debt, excluding current portion
Pension benefit obligations
Postretirement benefit obligations
Noncurrent deferred tax liabilities
Other taxes payable
Other noncurrent liabilities
Noncurrent liabilities
Total liabilities
Preferred stock, no par value, at stated value
Common stock, $0.05 par value
Additional paid-in capital
Treasury stock, shares at cost
Retained earnings
Accumulated other comprehensive loss
Total Pfizer Inc. shareholders’ equity
Equity attributable to noncontrolling interests
Total equity
Total liabilities and equity

Based on: 10-K (filing date: 2021-02-25), 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Pfizer Inc.’s current liabilities as a percentage of total liabilities and equity increased from 2018 to 2019 but then decreased significantly from 2019 to 2020.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Pfizer Inc.’s noncurrent liabilities as a percentage of total liabilities and equity decreased from 2018 to 2019 but then increased from 2019 to 2020 exceeding 2018 level.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Pfizer Inc.’s total liabilities as a percentage of total liabilities and equity increased from 2018 to 2019 but then decreased significantly from 2019 to 2020.
Total Pfizer Inc. shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Pfizer Inc.’s total Pfizer Inc. shareholders’ equity as a percentage of total liabilities and equity decreased from 2018 to 2019 but then increased from 2019 to 2020 exceeding 2018 level.